✦ LIBER ✦

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

✍ Scribed by Paul Angulo; Roberta A Jorgensen; Keith D Lindor

Book ID: 119391910
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 155 KB
Volume: 96
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)03832-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atorvastatin in patients with primary bi

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

✍ Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of

Pilot study: fenofibrate for patients wi

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Biochemical response to ursodeoxycholic

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony And 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Biochemical response to ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) is variable. It has been recently proposed that an alkaline phosphatase (ALP) decline of more than 40% in baseline value or a normal level after 1 year of UDCA treatment (Barcelona criteria) could se

666 BEZAFIBRATE TREATMENT FOR PATIENTS W

666 BEZAFIBRATE TREATMENT FOR PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAVE AN INCOMPLETE RESPONSE TO URSODEOXYCHOLIC ACID THERAPY

✍ R. Hazzan; R. Tur-Kaspa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Biochemical and immunologic effects of r

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ Masanobu Tsuda; Yuki Moritoki; Zhe-Xiong Lian; Weici Zhang; Katsunori Yoshida; K 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

A randomized trial comparing colchicine

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis

✍ R E Poupon; P M Huet; R Poupon; A Bonnand; J T Van Nhieu; E S Zafrani 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2-year controlled study. Seventy-four patients with PBC who had been treated previously with UDCA (at least 8 months) b